UPDATE 2-U.S. biotech companies Alnylam, Dicerna settle trade secrets case
April 20, 2018 at 13:51 PM EDT
BOSTON, April 20 (Reuters) - Alnylam Pharmaceuticals Inc said on Friday that Dicerna Pharmaceuticals Inc will pay it $25 million in cash and stock to resolve a lawsuit claiming it stole trade secrets about gene-silencing technology used to develop drug treatments.